Synchronyx Named Finalist in Therapeutics, Pharmacy & Medication Innovation at the 2026 Digital Health & AI Awards

Tappt® connects everyday medication use with patient support and clinical workflows, helping pharmacy and healthcare teams identify concerns between encounters.

Boca Raton, Florida, October 19, 2026.

Synchronyx has been named one of six Rising Star finalists in the Therapeutics, Pharmacy & Medication Innovation category of the Digital Health Hub Foundation’s 2026 Digital Health & AI Awards.

This year’s finalists were selected from more than 1,300 participating companies worldwide through a multi-stage evaluation by hundreds of judges across healthcare, technology, clinical medicine, and investment.

Synchronyx turns each medication into a connected care experience through Tappt®. With a simple tap, patients can track medication use, report symptoms, access guidance, and communicate with their care team. These interactions bring the patient’s experience into clinical workflows, connecting everyday treatment challenges with timely, informed support.

For pharmacy and healthcare teams, this approach provides a more complete view of the patient journey beyond prescribing, dispensing, and scheduled visits. Medication-use patterns, reported symptoms, and treatment barriers help teams identify patients who may be at risk, prioritize outreach, and direct resources where support is most needed.

“Much of a patient’s treatment journey happens between encounters, when missed doses, side effects, and practical barriers can remain unseen,” said Tamar Sapir, PhD, founder and CEO of Synchronyx. “We turn each medication into a connection to ongoing support, giving patients a simple way to share their experience and helping pharmacy and healthcare teams see the story behind medication use. By bringing that story into clinical workflows, we help teams recognize concerns earlier, prioritize patients who need attention, and maintain continuity through treatment and care transitions.”

The Digital Health Hub Foundation Awards recognize organizations advancing healthcare delivery, access, and patient outcomes through digital technology.

“The transition from Quarterfinalist to Finalist is where the competition really gets exciting,” said Mark H. Goldstein, Chairman of the Digital Health Hub Foundation. “We’re seeing companies move beyond promising ideas to solutions that are changing how healthcare is delivered, experienced, and accessed. Our finalists represent an extraordinary range of innovation, and we can’t wait to bring their achievements to the stage at HLTH in November.”

Winners will be announced on Monday, November 16, at HLTH USA at The Venetian in Las Vegas. The Therapeutics, Pharmacy & Medication Innovation category will be featured during “The Future of Medicine” awards show at 2:30 p.m.

Synchronyx will participate in the Awards Pavilion at booth 1151-40. Healthcare leaders, pharmacy teams, life sciences organizations, and research partners are invited to meet the team and explore its approach to medication intelligence and connected care. To arrange a meeting, contact Synchronyx through www.synchronyx.com.

About Synchronyx

Synchronyx is a healthcare technology company connecting patients and care teams through medication intelligence and accessible support. Its Tappt® platform turns each medication into a connected care experience, bringing together medication adherence monitoring, patient-reported symptoms, education, and direct communication.

Integrated into clinical workflows, these interactions help pharmacy and healthcare teams understand patients’ experiences between encounters, surface actionable concerns, and coordinate follow-up to support adherence, retention in care, and continuity across care settings. Linkt™ extends this connection to care navigation and transitions of care, helping patients access their care team for guidance on medications, symptoms, follow-up, and recovery after discharge.

Tappt® has been evaluated in peer-reviewed studies and adopted by health systems, academic medical centers, and pharmacies. Synchronyx supports programs across clinical care, patient support, remote monitoring, and research. Learn more at www.synchronyx.com.

About Digital Health Hub Foundation

Founded in 2017 on the campus of UCSF in San Francisco, the Digital Health Hub Foundation helps healthcare technology companies scale and grow. Its community of more than 30,000 members includes healthcare companies, providers, payors, industry experts, mentors, investors, clinicians, and researchers. Its annual Digital Health & AI Awards recognize technological advances in healthcare and their impact.

Media contact
info@synchronyx.com

Next
Next

From discharge plan to supported recovery